- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT04132856
Mapping Psychosocial Screening to Services for Children With Cancer
Mapping Psychosocial Screening to Services for Children With Cancer: Feasibility and Pilot Study
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Background: Approximately 3 000 children and adolescents are diagnosed with cancer in Canada each year [Canadian Cancer Society]. Children with cancer experience higher rates of anxiety and depression symptoms relative to healthy controls [Pinquart & Shen, 2011], and a subgroup are vulnerable to marked levels of psychological distress [Kurtz & Abrams, 2011]. One standard for psychosocial care in pediatric cancer that is starting to be implemented across the United Stated and Canada is the systematic screening for psychosocial distress, using the Psychosocial Assessment Tool (PAT) [Kazak, Schneider, Didonato, Pai, 2015; Pai et al., 2008; Barrera et al., 2014; McCarthy et al., 2009; Sint Nicolaas et al., 2016]. However, a dearth of literature exists on how to bridge screening for psychosocial distress and the delivery of appropriate evidence-based mental health resources. The current study is a randomized controlled pilot intervention project which aims to test the feasibility and effects of introducing a psychosocial navigator who will coordinate the delivery of psychosocial resources to children with cancer and their families based on early screening and follow-up for psychosocial distress. Specific Objectives: 1) To determine the feasibility and utility of conducting psychosocial screening and providing an Enhanced Psychosocial Intervention (EPSI). 2) To examine the effects of EPSI, as compared to treatment as usual (TAU+), on the mental health, quality of life, coping, and social relationships of children with cancer. Methods: A randomized controlled feasibility intervention trial, with a TAU+ control group, will be conducted with newly diagnosed children with any type of cancer. Participants will be 10-18 years of age, medically suitable for participation, in active treatment, and the primary caregiver. Forty-eight child-caregiver dyads (24 in the intervention and 24 in the control group) will be enrolled. The EPSI will have two components: 1) Information about the psychosocial risk of the family and mental health of the child (e.g., depression) and 2) the Psychosocial Navigator (PSN) as resource for tailoring psychosocial resources to child-family distress, linking with the treating team. Measures of feasibility (recruitment, acceptability) will be documented throughout; initial screening using the PAT will be conducted 2-4 weeks post diagnosis (baseline); and using the distress thermometer, follow-up will be done at specific periods depending on the disease (leukemia/lymphoma, solid tumors, brain tumors). The primary psychosocial outcome (depression), and secondary outcomes (post-traumatic stress, pain, fatigue, coping, sleep quality, time and financial cost, social support and quality of life) will be completed at baseline and 12 months later. Descriptive statistics (frequency and percentage rates) will be provided for feasibility measures and PAT psychosocial risk categories. Means, standard deviations, and ranges will be provided for the primary and secondary outcomes. Preliminary analyses of group comparisons will also be performed via independent t tests and chi square tests. Further, analyses of covariance (ANCOVAs) will be conducted on the primary and secondary outcomes to test group differences at post-test while controlling for pretest scores.
Significance: The proposed intervention project will assess and address the psychosocial needs of newly diagnosed pediatric cancer patients and families. This intervention aims to improve the triaging of resources and enhance the effectiveness of psychosocial intervention for children with cancer. The enhanced intervention is expected to improve children's and adolescents' coping with disease-related stressors such as pain and uncertainty, improve their mood, and enhance social engagement with peers.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Ontario
-
Toronto, Ontario, Kanada, M4G 3R9
- Hospital for Sick Children
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Between 10 and 18 years of age
- Clinical diagnosis of cancer
- Less than 4 weeks since diagnosis disclosure
- Primary caregiver must also consent to participation
Exclusion Criteria:
- Cancer diagnosis disclosed more than 4 weeks ago.
- Primary caregiver declines to participate
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Ekranizacja
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Podwójnie
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Intervention Group
The Intervention group will receive the services of the Psychosocial Navigator (PSN) monthly for the full 12 months of the study.
At baseline, the PSN will provide the health care providers (HCPs) and family with recommendations for mapping and triaging of resources to levels of psychosocial risk (PAT: Universal, Targeted, Clinical) and level of depression and anxiety (mild, moderate, and high mental health problems; as determined by the standardized norms for the measures).
This information will be summarized in the Communication Summary Profile and shared with the treating team (oncologist, nurse, and Social Worker, core psychosocial staff involved in the child's care) and family within 48 hours of completion.
The PSN will conduct follow-up psychosocial screenings on a monthly basis, using the Distress Thermometer for children and caregivers.
Results of the monthly assessments and recommended resources will also be communicated to the caregiver/parent and treating team of the youth.
|
Services of psychosocial navigator
Both patient/caregiver dyad and HCPs will receive a summary of the PAT results and levels of depression and anxiety.
|
Brak interwencji: Treatment as Usual Group
Current psychosocial care services will be accessible to Treatment as Usual Group (e.g., social work, child life, psychology, art and music therapy, and psychiatry).
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Feasibility pertaining to recruitment
Ramy czasowe: 12 months
|
Rate of recruitment as measured by percentage of participants who consent to participation as compared to those who are eligible and do not consent
|
12 months
|
Feasibility pertaining to retention
Ramy czasowe: 12 months
|
Rates of completed questionnaires at all time points
|
12 months
|
Satisfaction with Enhanced Intervention as assessed by questionnaire at completion of study
Ramy czasowe: 12 months
|
5 - point likert scale satisfaction questionnaire with 6 questions pertaining to usefulness and overall satisfaction with the enhanced intervention.
The minimum score is 6 (low satisfaction) and the maximum score is 30 (high satisfaction).
|
12 months
|
Satisfaction with Enhanced Intervention as assessed by semi-structured interview at completion of study
Ramy czasowe: 12 months
|
Semi-structured interview with 6 questions including "What were your expectations about being in this study?";
"Were your expectations of the study met?"; "Do you have any additional comments/suggestions for the study?"
|
12 months
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Distress
Ramy czasowe: Change from baseline to 12 months
|
Pediatric and Adult Distress Thermometer (self-report) measures participant distress on a visual analog scale of 1 to 10, with a score of 10 indicating high distress
|
Change from baseline to 12 months
|
Patient generic quality of life based on self report
Ramy czasowe: Change from baseline to 12 months
|
Pediatric Quality of Life - generic.
(Child/teen self-report).
Measures perceived quality of life of child with cancer based on self perception - on everyday items (for children who do not have cancer).
Miinimum score is 0. Maximum score is 100.
Higher score indicates better perceived quality of life.
|
Change from baseline to 12 months
|
Patient generic quality of life based on caregiver report
Ramy czasowe: Change from baseline to 12 months
|
Pediatric Quality of Life - generic.
(Caregiver-report).
Measures perceived quality of life of child with cancer based on caregiver perception - on everyday items (for children who do not have cancer).
Miinimum score is 0. Maximum score is 100.
Higher score indicates better perceived quality of life.
|
Change from baseline to 12 months
|
Patient quality of life as it relates to cancer, based on self-report
Ramy czasowe: Change from baseline to 12 months
|
Pediatric Quality of Life-Cancer (Child/teen self-report).
Measures perceived quality of life of child with cancer based on self-perception.
Miinimum score is 0. Maximum score is 100.
Higher score indicates better perceived quality of life.
|
Change from baseline to 12 months
|
Patient quality of life as it relates to cancer, based on caregiver report
Ramy czasowe: Change from baseline to 12 months
|
Pediatric Quality of Life-Cancer (Caregiver report).
Measures perceived quality of life of child with cancer based on caregiver perception.
Miinimum score is 0. Maximum score is 100.
Higher score indicates better perceived quality of life.
|
Change from baseline to 12 months
|
Patient anxiety and depression - child/teem self report
Ramy czasowe: Change from baseline to 12 months
|
Pediatric Index of Emotional Distress.
Minimum score is 0. Maximum score is 42.
Lower score indicates lower levels of anxiety and depression.
|
Change from baseline to 12 months
|
Patient anxiety (child/teen self-report)
Ramy czasowe: Change from baseline to 12 months
|
Patient-reported Outcomes Measurement Information System (PROMIS) - pediatric anxiety questionnaire - short form (child/teen self-report).
Minimum score is 8. Maximum score is 40.
Lower score indicates lower level of anxiety.
|
Change from baseline to 12 months
|
Patient depression (child/teen self-report)
Ramy czasowe: Change from baseline to 12 months
|
Patient-reported Outcomes Measurement Information System (PROMIS) - pediatric depression questionnaire - short form (child/teen self-report).
Minimum score is 8. Maximum score is 40.
Lower score indicates lower level of depression.
|
Change from baseline to 12 months
|
Caregiver post-traumatic stress related to child's cancer diagnosis
Ramy czasowe: Change from baseline to 12 months
|
Impact of Events scale - Revised (IES-R) (caregiver self-report).
Mimimum score is 0. Maximum score is 88.
Lower scores indicate lower levels of post-traumatic stress.
|
Change from baseline to 12 months
|
Patient post-traumatic stress related to own cancer diagnosis
Ramy czasowe: Change from baseline to 12 months
|
Impact of Events scale - Revised (IES-R) (child/teen self-report).
Mimimum score is 0. Maximum score is 88.
Lower scores indicate lower levels of post-traumatic stress.
|
Change from baseline to 12 months
|
Caregiver coping with stress of child's cancer diagnosis
Ramy czasowe: Change from baseline to 12 months
|
Responses to Stress Questionnaire - Cancer Version (caregiver self-report).
Minimum score is 0. Maximum score is 1.
A higher score indicates more engagement with active coping strategies.
|
Change from baseline to 12 months
|
Patient's own coping with stress of cancer diagnosis
Ramy czasowe: Change from baseline to 12 months
|
Response to Stress Questionnaire - Cancer Version (patient self-report).
Minimum score is 0. Maximum score is 1.
A higher score indicates more engagement with active coping strategies.
|
Change from baseline to 12 months
|
Psychosocial risk
Ramy czasowe: Change from baseline to 12 months
|
Psychosocial Assessment Tool (PAT) (caregiver report).
Minimum score is 0. Maximum score is 3. Lower score indicates lower level of psychosocial risk.
|
Change from baseline to 12 months
|
Financial impact of pediatric cancer diagnosis and treatment on families.
Ramy czasowe: Change from baseline to 12 months
|
Financial burden questionnaire (caregiver report).
Minimum score is 22. Maximum score is 88.
Higher score indicates lower level of financial impact on families.
|
Change from baseline to 12 months
|
Caregiver depression
Ramy czasowe: Change from baseline to 12 months
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Questionnaire (caregiver self-report).
Minimum score is 6.
Maximum score is 30.
Lower scores indicate lower levels of depression.
|
Change from baseline to 12 months
|
Caregiver anxiety
Ramy czasowe: Change from baseline to 12 months
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Questionnaire (caregiver self-report).
Minimum score is 6.
Maximum score is 30.
Lower scores indicate lower levels of anxiety.
|
Change from baseline to 12 months
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Sleep duration and quality of sleep of patient and caregiver
Ramy czasowe: Change from baseline to 12 months
|
Pittsburgh Sleep Quality Index.
(Caregiver and patient self-report).
Minimum value is 0. Maximum value is 21.
Lower scores indicate better sleep quality.
|
Change from baseline to 12 months
|
Caregiver emotional support
Ramy czasowe: Change from baseline to 12 months
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Support Questionnaire (caregiver self-report).
Minimum score is 6.
Maximum score is 30.
Higher scores indicate higher levels of emotional support.
|
Change from baseline to 12 months
|
Caregiver Fatigue
Ramy czasowe: Change from baseline to 12 months
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Questionnaire (caregiver self-report).
Minimum score is 6.
Maximum score is 30.
Lower scores indicate lower levels of fatigue
|
Change from baseline to 12 months
|
Patient Peer Relationships
Ramy czasowe: Change from baseline to 12 months
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Perceived Quality of Peer Relationships (child/teen self-report).
Minimum score is 8. Maximum score is 40.
Higher scores indicate higher levels of perceived peer relationship quality.
|
Change from baseline to 12 months
|
Patient Fatigue
Ramy czasowe: Change from baseline to 12 months
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Questionnaire (child/teen self-report).
Minimum score is 10.
Maximum score is 50.
Lower scores indicate lower levels of fatigue.
|
Change from baseline to 12 months
|
Patient emotional support
Ramy czasowe: Change from baseline to 12 months
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Support Questionnaire (child/teen self-report).
Minimum score is 7. Maximum score is 35.
Higher scores indicate higher levels of emotional support.
|
Change from baseline to 12 months
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: Maru Barrera, PhD, The Hospital for Sick Children
Publikacje i pomocne linki
Publikacje ogólne
- Barrera M, Hancock K, Rokeach A, Cataudella D, Atenafu E, Johnston D, Punnett A, Nathan PC, Bartels U, Silva M, Cassidy M, Jansen P, Shama W, Greenberg C. External validity and reliability of the Psychosocial Assessment Tool (PAT) among Canadian parents of children newly diagnosed with cancer. Pediatr Blood Cancer. 2014 Jan;61(1):165-70. doi: 10.1002/pbc.24774. Epub 2013 Sep 17.
- Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2015. Toronto, ON: Canadian Cancer Society; 2015.
- Pinquart M, Shen Y. Behavior problems in children and adolescents with chronic physical illness: a meta-analysis. J Pediatr Psychol. 2011 Oct;36(9):1003-16. doi: 10.1093/jpepsy/jsr042. Epub 2011 Aug 1.
- Kurtz BP, Abrams AN. Psychiatric aspects of pediatric cancer. Pediatr Clin North Am. 2011 Aug;58(4):1003-23, xii. doi: 10.1016/j.pcl.2011.06.009.
- Kazak AE, Schneider S, Didonato S, Pai AL. Family psychosocial risk screening guided by the Pediatric Psychosocial Preventative Health Model (PPPHM) using the Psychosocial Assessment Tool (PAT). Acta Oncol. 2015 May;54(5):574-80. doi: 10.3109/0284186X.2014.995774. Epub 2015 Mar 9.
- Pai AL, Patino-Fernandez AM, McSherry M, Beele D, Alderfer MA, Reilly AT, Hwang WT, Kazak AE. The Psychosocial Assessment Tool (PAT2.0): psychometric properties of a screener for psychosocial distress in families of children newly diagnosed with cancer. J Pediatr Psychol. 2008 Jan-Feb;33(1):50-62. doi: 10.1093/jpepsy/jsm053. Epub 2007 Jul 3.
- McCarthy MC, Clarke NE, Vance A, Ashley DM, Heath JA, Anderson VA. Measuring psychosocial risk in families caring for a child with cancer: the Psychosocial Assessment Tool (PAT2.0). Pediatr Blood Cancer. 2009 Jul;53(1):78-83. doi: 10.1002/pbc.22007.
- Sint Nicolaas SM, Schepers SA, Hoogerbrugge PM, Caron HN, Kaspers GJ, van den Heuvel-Eibrink MM, Grootenhuis MA, Verhaak CM. Screening for Psychosocial Risk in Dutch Families of a Child With Cancer: Reliability, Validity, and Usability of the Psychosocial Assessment Tool. J Pediatr Psychol. 2016 Aug;41(7):810-9. doi: 10.1093/jpepsy/jsv119. Epub 2015 Dec 29.
- Desjardins L, Hancock K, Szatmari P, Alexander S, Shama W, De Souza C, Mills D, Abla O, Barrera M. Protocol for mapping psychosocial screening to resources in pediatric oncology: a pilot randomized controlled trial. Pilot Feasibility Stud. 2021 Jul 17;7(1):143. doi: 10.1186/s40814-021-00878-0.
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Inne numery identyfikacyjne badania
- 1000056445
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Nowotwór
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Aktywny, nie rekrutującyGruczolakorak gruczołu krokowego III stopnia AJCC v7 | Gruczolakorak gruczołu krokowego II stopnia AJCC v7 | Stopień I gruczolakoraka gruczołu krokowego American Joint Committee on Cancer (AJCC) v7Stany Zjednoczone
-
Emory UniversityNational Cancer Institute (NCI)WycofanePrognostyczny rak piersi IV stopnia AJCC v8 | Przerzutowy nowotwór złośliwy w mózgu | Przerzutowy rak piersi | Anatomiczny IV stopień raka piersi American Joint Committee on Cancer (AJCC) v8
-
Jonsson Comprehensive Cancer CenterZakończonyRak prostaty oporny na kastrację | Przerzutowy rak prostaty | Stadium IVA raka prostaty AJCC v8 | Rak prostaty w stadium IVB AJCC v8 | Rak prostaty w stadium IV American Joint Committee on Cancer (AJCC) v8Stany Zjednoczone
-
Jonsson Comprehensive Cancer CenterZakończonyBiochemicznie nawracający rak prostaty | Przerzutowy rak prostaty | Nowotwór złośliwy z przerzutami w kości | Stadium IVA raka prostaty AJCC v8 | Rak prostaty w stadium IVB AJCC v8 | Rak prostaty w stadium IV American Joint Committee on Cancer (AJCC) v8Stany Zjednoczone
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.RekrutacyjnyNiedrobnokomórkowy rak płuc z przerzutami | Oporny na leczenie niedrobnokomórkowy rak płuc | Rak płuca w stadium IV American Joint Committee on Cancer (AJCC) v8 | Rak płuc w stadium IVA AJCC v8 | Rak płuc w stadium IVB AJCC v8Stany Zjednoczone
-
NRG OncologyNational Cancer Institute (NCI)Aktywny, nie rekrutującyAnatomiczny rak piersi IV stadium AJCC v8 | Prognostyczny rak piersi IV stopnia AJCC v8 | Nowotwór złośliwy z przerzutami w kości | Przerzutowy nowotwór złośliwy w węzłach chłonnych | Przerzutowy nowotwór złośliwy w wątrobie | Przerzutowy rak piersi | Przerzutowy nowotwór złośliwy w płucach | Nowotwór... i inne warunkiStany Zjednoczone, Kanada, Arabia Saudyjska, Republika Korei
-
Jonsson Comprehensive Cancer CenterRekrutacyjnyRak prostaty oporny na kastrację | Przerzutowy rak prostaty | Stadium IVA raka prostaty AJCC v8 | Rak prostaty w stadium IVB AJCC v8 | Rak prostaty w stadium IV American Joint Committee on Cancer (AJCC) v8Stany Zjednoczone
-
National Cancer Institute (NCI)ZakończonyOporny na leczenie złośliwy nowotwór lity | Nawracający złośliwy nowotwór lity | Przerzutowy złośliwy nowotwór lity | Nieoperacyjny lity nowotwór | Nawracający rak drobnokomórkowy płuca | Stopień IIIA Rak drobnokomórkowy płuca AJCC v7 | Etap IIIB Rak drobnokomórkowy płuca AJCC v7 | Rak drobnokomórkowy... i inne warunkiStany Zjednoczone
-
Jonsson Comprehensive Cancer CenterBeiGene; Driven To CureWycofanePrzerzutowy rak nerkowokomórkowy | Rak nerkowokomórkowy IV stopnia AJCC v8 | Rak brodawkowaty nerki | Zbieranie raka przewodów | Nieoperacyjny rak nerki | Dziedziczna leiomyomatoza i rak nerkowokomórkowy | Jasnokomórkowy brodawkowaty nowotwór nerki | Dziedziczny rak brodawkowaty nerki | Niesklasyfikowany... i inne warunkiStany Zjednoczone
-
Jonsson Comprehensive Cancer CenterAstraZenecaZakończonyRak płaskonabłonkowy jamy ustnej i gardła | Stopień kliniczny III zależny od HPV (p16-dodatni) rak jamy ustnej i gardła AJCC v8 | Stopień kliniczny II, w którym pośredniczy HPV (p16-dodatni) rak jamy ustnej i gardła AJCC v8 | Patologiczny etap I, w którym pośredniczy HPV (p16-dodatni) rak jamy... i inne warunkiStany Zjednoczone
Badania kliniczne na Psychosocial Navigator
-
Florida State UniversityDuquesne UniversityRekrutacyjnyKomunikacja społecznaStany Zjednoczone
-
University Medical Centre LjubljanaKarolinska Institutet; Schneider Children's Medical Center, IsraelZakończonyHipoglikemia | Cukrzyca typu 1Szwecja, Izrael, Słowenia
-
Florida State UniversityNational Institute of Mental Health (NIMH); Emory University; Weill Medical College... i inni współpracownicyZakończonyZaburzenia ze spektrum autyzmuStany Zjednoczone
-
University of California, Los AngelesZakończony
-
University of Wisconsin, MadisonAurora Health CareZakończonyRak piersi | Rak jelita grubego | Rak płuc | Rak prostatyStany Zjednoczone
-
Children's Hospital Medical Center, CincinnatiOffice of Head StartZakończony
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) i inni współpracownicyZakończonyChroniczny ból | Zespół przewlekłego bólu | Przewlekły ból, powszechny | Przewlekły ból spowodowany urazem | Przewlekły ból spowodowany chorobą nowotworową (znalezienie) | Przewlekły ból spowodowany urazem | Przewlekły ból po zabiegu | Przewlekły ból biodraZjednoczone Królestwo
-
University of Illinois at ChicagoRekrutacyjnyRak szyjki macicy | ZachowanieSenegal
-
Lawson Health Research InstituteBoston Scientific CorporationZakończony
-
Illinois Institute of TechnologyPatient-Centered Outcomes Research Institute; TrilogyZakończonyZaburzenia psychiczneStany Zjednoczone